Cargando…
Visual Outcomes after Implantation of Lucidis EDOF IOL
PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 month...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167139/ https://www.ncbi.nlm.nih.gov/pubmed/35669466 http://dx.doi.org/10.1155/2022/5100861 |
_version_ | 1784720766259953664 |
---|---|
author | Rabinovich, Mark Ceresara, Gaia Aramburu del Boz, Ana Al Khatib, Danial Crespe, Marie Bovet, Jerome |
author_facet | Rabinovich, Mark Ceresara, Gaia Aramburu del Boz, Ana Al Khatib, Danial Crespe, Marie Bovet, Jerome |
author_sort | Rabinovich, Mark |
collection | PubMed |
description | PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 months following surgery. MATERIALS AND METHODS: We reviewed retrospectively 181 eyes of 98 patients, who underwent cataract surgery with Lucidis extended depth of focus IOL. RESULTS: 44 patients were males (45%) and 54 were females (55%). The average age of the study population was 68 ± 11 years. The mean preoperative BCVA (logMAR) was 0.19 ± 0.18. The mean root mean square (RMS) high order aberration (HOA) was 0.18 ± 0.1. Monocular BCVA results were 0.02 ± 0.04 (logMAR) and 0.028 ± 0.04 (logMAR) 1 month and 3 months postoperatively, respectively. Between the baseline and 1-month measures, monocular distance BCVA improved by an average of 0.17 ± 0.14 logMAR (p = 0.0001). Between the baseline and 3-month postoperative measures, monocular distance BCVA improved by an average of 0.16 ± 0.13 logMAR (p = 0.0001). Monocular UDVA 1 and 3 months postoperatively was 0.08 ± 0.1 logMAR and 0.067 ± 0.08 logMAR, respectively. 1-Month postoperative binocular UDVA was 0.036 ± 0.05 logMAR, binocular UIVA was 0.1 ± 0.08 logMAR, and binocular UNVA was 0.12 ± 0.14 logMAR. 3-Month postoperative binocular UDVA was 0.038 ± 0.05 logMAR, binocular UIVA was 0.09 ± 0.1 logMAR, and binocular UNVA was 0.16 ± 0.14 logMAR. CONCLUSIONS: Lucidis EDOF IOL achieves good visual performances in all distances. |
format | Online Article Text |
id | pubmed-9167139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91671392022-06-05 Visual Outcomes after Implantation of Lucidis EDOF IOL Rabinovich, Mark Ceresara, Gaia Aramburu del Boz, Ana Al Khatib, Danial Crespe, Marie Bovet, Jerome J Ophthalmol Research Article PURPOSE: To evaluate the visual performance and clinical outcomes after implantation of Lucidis EDOF IOL following cataract surgery. DESIGN: In this retrospective study, medical records from all enrolled patients were analyzed, and the following information was extracted retrospectively over 3 months following surgery. MATERIALS AND METHODS: We reviewed retrospectively 181 eyes of 98 patients, who underwent cataract surgery with Lucidis extended depth of focus IOL. RESULTS: 44 patients were males (45%) and 54 were females (55%). The average age of the study population was 68 ± 11 years. The mean preoperative BCVA (logMAR) was 0.19 ± 0.18. The mean root mean square (RMS) high order aberration (HOA) was 0.18 ± 0.1. Monocular BCVA results were 0.02 ± 0.04 (logMAR) and 0.028 ± 0.04 (logMAR) 1 month and 3 months postoperatively, respectively. Between the baseline and 1-month measures, monocular distance BCVA improved by an average of 0.17 ± 0.14 logMAR (p = 0.0001). Between the baseline and 3-month postoperative measures, monocular distance BCVA improved by an average of 0.16 ± 0.13 logMAR (p = 0.0001). Monocular UDVA 1 and 3 months postoperatively was 0.08 ± 0.1 logMAR and 0.067 ± 0.08 logMAR, respectively. 1-Month postoperative binocular UDVA was 0.036 ± 0.05 logMAR, binocular UIVA was 0.1 ± 0.08 logMAR, and binocular UNVA was 0.12 ± 0.14 logMAR. 3-Month postoperative binocular UDVA was 0.038 ± 0.05 logMAR, binocular UIVA was 0.09 ± 0.1 logMAR, and binocular UNVA was 0.16 ± 0.14 logMAR. CONCLUSIONS: Lucidis EDOF IOL achieves good visual performances in all distances. Hindawi 2022-05-28 /pmc/articles/PMC9167139/ /pubmed/35669466 http://dx.doi.org/10.1155/2022/5100861 Text en Copyright © 2022 Mark Rabinovich et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Rabinovich, Mark Ceresara, Gaia Aramburu del Boz, Ana Al Khatib, Danial Crespe, Marie Bovet, Jerome Visual Outcomes after Implantation of Lucidis EDOF IOL |
title | Visual Outcomes after Implantation of Lucidis EDOF IOL |
title_full | Visual Outcomes after Implantation of Lucidis EDOF IOL |
title_fullStr | Visual Outcomes after Implantation of Lucidis EDOF IOL |
title_full_unstemmed | Visual Outcomes after Implantation of Lucidis EDOF IOL |
title_short | Visual Outcomes after Implantation of Lucidis EDOF IOL |
title_sort | visual outcomes after implantation of lucidis edof iol |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167139/ https://www.ncbi.nlm.nih.gov/pubmed/35669466 http://dx.doi.org/10.1155/2022/5100861 |
work_keys_str_mv | AT rabinovichmark visualoutcomesafterimplantationoflucidisedofiol AT ceresaragaia visualoutcomesafterimplantationoflucidisedofiol AT aramburudelbozana visualoutcomesafterimplantationoflucidisedofiol AT alkhatibdanial visualoutcomesafterimplantationoflucidisedofiol AT crespemarie visualoutcomesafterimplantationoflucidisedofiol AT bovetjerome visualoutcomesafterimplantationoflucidisedofiol |